Exchange: NYSE·Updated 07:30 PM EST

AORT News

News
all
press releases
Artivion (AORT) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Artivion (AORT) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
Artivion (AORT) delivered earnings and revenue surprises of -27.27% and +1.97%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Artivion Reports Third Quarter 2026 Financial Results Artivion Reports Third Quarter 2026 Financial ResultsPR NewswireATLANTA, Nov. 5, 2026 Third Quarter & Recent Business Highlights: Achieved revenue of $123.8 million in the third quarter of 2026 versus $113.4 million in the third quarter of 2025...
PR Newswire
Artivion to Participate in Upcoming Investor Conferences Artivion to Participate in Upcoming Investor ConferencesPR NewswireATLANTA, Oct. 28, 2026 ATLANTA, Oct. 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today...
PR Newswire
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +8.00% and +6.01%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial ResultsPR NewswireATLANTA, Oct. 22, 2026 ATLANTA, Oct. 22, 2026 /PRNewswire/ -- Artivion, Inc...
PR Newswire
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Artivion (AORT) delivered earnings and revenue surprises of 0.00% and +4.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Artivion Reports Second Quarter 2026 Financial Results Artivion Reports Second Quarter 2026 Financial Results PR Newswire ATLANTA, Aug. 6, 2026 Second Quarter & Recent Business Highlights: Achieved revenue of $125.8 million in the second quarter of 2026 versus $113.0 million in the second quarter...
PR Newswire
Steris (STE) delivered earnings and revenue surprises of +1.97% and -0.83%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.